. For more than a decade the ICMJE has included the necessity for prospective clinical trial registration as part of those recommendations and, in 2017, the recommendations were updated to include a requirement for data sharing statements in publications reporting clinical trials 3 . While some journals have required data sharing statements for a number of years already 4 , this was mandated for ICMJE member journals from July 2018, and for trials commencing after January 2019, the clinical trial registration will also need to include a data sharing statement The reasoning behind this initiative was detailed in an editorial jointly published by the ICMJE member journals 6 and also previously 4 . The overriding principle is transparency, but there is also an ethical obligation to ensure that individual participant data collected as part of clinical trials, and for which those participants may have been exposed to risk, might be used to derive the greatest possible public benefit.
In line with the updated ICMJE recommendations, Anaesthesia and Intensive Care will expect all submissions after the publication of this editorial to include data sharing statements which, quoting from the relevant documents 3, 6 , must indicate the following: whether individual de-identified participant data (including data dictionaries) will be shared; what data in particular will be shared; whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism). The ICMJE has also provided a number of illustrative examples 3, 6 . We encourage investigators where possible to archive their de-identified data in a public repository as illustrated in Example 1 suggested by the ICMJE 3, 6 . One potential option might be med.data.edu.au 7 , a nationally-funded facility to provide research data storage, compliant with national and state privacy and policy requirements, to Australian medical and health research organisations, and which is already partnered with a large number of Australian universities and other major research bodies. Alternatively, one of the recommended international research data repositories (such as Dryad 8 or Figshare   9 ) or an institutional repository might be suitable archives. Further information with some emphasis on our region is available from the Australian National Data Service 10 (specific information about data repositories can be found in the Medical and Health Data section). In the near future we expect the Anaesthesia and Intensive Care website and submission portal will be integrated with one or more of the major repositories so authors will be able to permanently archive datasets during the submission process if they have not done so already, and individual participant data will become an integrated part of the publication. The benefits are considerable: datasets can be given specific digital object identifiers rendering them citable and accessible indefinitely.
The scientific publishing landscape is changing and evolving rapidly. Authors and readers can expect to see a number of necessary initiatives implemented at the Journal over coming months; this open data policy, which is itself likely to further evolve, being one of the first. We are confident this evolution will make Anaesthesia and Intensive Care all the more relevant, accessible and beneficial for Society members and other users of the Journal.
